- Home
- BLCO vs BIPC Comparison
BLCO vs BIPC Comparison
Compare BLCO & BIPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- BIPC
- Stock Information
- Founded
- BLCO 1853
- BIPC 2019
- Country
- BLCO Canada
- BIPC United States
- Employees
- BLCO N/A
- BIPC N/A
- Industry
- BLCO Ophthalmic Goods
- BIPC Marine Transportation
- Sector
- BLCO Health Care
- BIPC Consumer Discretionary
- Exchange
- BLCO Nasdaq
- BIPC Nasdaq
- Market Cap
- BLCO 4.4B
- BIPC 4.7B
- IPO Year
- BLCO 2022
- BIPC N/A
- Fundamental
- Price
- BLCO $11.70
- BIPC $40.77
- Analyst Decision
- BLCO Hold
- BIPC
- Analyst Count
- BLCO 13
- BIPC 0
- Target Price
- BLCO $15.63
- BIPC N/A
- AVG Volume (30 Days)
- BLCO 578.9K
- BIPC 684.8K
- Earning Date
- BLCO 07-30-2025
- BIPC 01-01-0001
- Dividend Yield
- BLCO N/A
- BIPC 4.25%
- EPS Growth
- BLCO N/A
- BIPC N/A
- EPS
- BLCO N/A
- BIPC N/A
- Revenue
- BLCO $4,829,000,000.00
- BIPC $3,693,000,000.00
- Revenue This Year
- BLCO $6.97
- BIPC $8.95
- Revenue Next Year
- BLCO $5.48
- BIPC $6.21
- P/E Ratio
- BLCO N/A
- BIPC N/A
- Revenue Growth
- BLCO 11.94
- BIPC 26.99
- 52 Week Low
- BLCO $10.45
- BIPC $32.08
- 52 Week High
- BLCO $21.69
- BIPC $43.26
- Technical
- Relative Strength Index (RSI)
- BLCO 45.65
- BIPC 56.62
- Support Level
- BLCO $11.44
- BIPC $41.01
- Resistance Level
- BLCO $12.70
- BIPC $41.99
- Average True Range (ATR)
- BLCO 0.36
- BIPC 0.75
- MACD
- BLCO 0.01
- BIPC -0.12
- Stochastic Oscillator
- BLCO 30.07
- BIPC 58.50
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About BIPC Brookfield Infrastructure Corporation
Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom and the United States.